Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.42(2026) • Internal Medicine Electron Transport Chain Modulation of Dendritic Cells... 3 min read
Article NL C.42(2026) • Internal Medicine Glucocorticoid Receptor Activation as a Driver of... 3 min read
Article NL C.42(2026) • Internal Medicine Broad Spectrum Immunogenicity of Dual-Immunogen... 3 min read
Article NL C.42(2026) • Internal Medicine Cancer-Cell Autonomous Inflammatory Signaling as a... 3 min read